摘要
目的:研究基因沉默Survivin对视网膜母细胞瘤HXO-RB44细胞凋亡、侵袭以及血管内皮生长因子(VEGF)、基质金属蛋白酶2(MMP-2)、基质金属蛋白酶9(MMP-9)活性的影响。方法:培养视网膜母细胞瘤HXO-RB44细胞,构建Survivin-shRNA载体。按照处理不同分为Survivin-shRNA组、GFP组和CON组。分别检测三组HXO-RB44细胞凋亡指数、细胞侵袭能力以及VEGF、MMP-2、MMP-9、CAS-3蛋白的表达水平。结果:流式细胞术结果表明,与CON组和GFP组相比,Survivin-shRNA组细胞凋亡率增加,差异有统计学意义(P<0.05);Transwell侵袭小室实验显示Survivin-shRNA能明显降低HXO-RB44细胞的侵袭能力;Western blot结果发现,Survivin-shRNA可降低VEGF、MMP-2、MMP-9蛋白的表达水平,并提高CAS-3的表达水平。结论:Survivin-shRNA可诱导HXO-RB44细胞凋亡,抑制细胞侵袭能力,下调血管形成相关因子VEGF、MMP-2、MMP-9的表达,进而抑制肿瘤新生血管的形成。
Objective:To explore the effects and molecular mechanisms of survivin-shRNA on tumor apoptosis,invasive capacity and Expression of Angiogenesis Related Factors of HXO-RB44 cells.Methods:HXO-RB44 cells were cultured in DMEM medium and recombinant adenovirus vector Survivin-shRNA and negative control rAd5-GFP were transfected into HXO-RB44 cells.Positive stable transfectants were selected and expanded for further study.The clone in which the rAd5-Survivin-shRNA virus vectors transfected was named as Survivin-shRNA group,the negative control vectors transfected was named as GFP group and HXO-RB44 cells were named as CON group.Flow cytometry detected apoptosis index.Transwell invasion assay detecteded cell invasive capacity.Western blot assay determined the protein expression level of VEGF,MMP-2,MMP-9 and CAS-3.Results:After Survivin-shRNA was transfected into HXO-RB44 cells,it was found that knockdown of Survivin markedly increased the apoptotic index of HXO-RB44 cells compared with GFP group and CON group indicated by flow cytometry. Transwell invasion assay showed that the cell invasive capacity in treated groups was markedly HXO-RB44 lower than the control group.Western blot assays performed that the protein expression level of VEGF,MMP-2,MMP-9 was decreased,while CAS-3 expression was increased in treated group compared with the CON group. Conclusion: Survivin-shRNA could induce apoptosis,inhibit invasive capacity,down-regulate the expression of angiogenesis related factors such as VEGF,MMP-2,MMP-9,and then inhibit angiogenesis of HXO-RB44 cells.
作者
秦静
周海燕
张坚
段大鹏
Qin Jing;Zhou Haiyan;Zhang Jian;Duan Dapeng(Shaanxi Provincial People's Hospital,Shaanxi Xi'an 710068,China)
出处
《现代肿瘤医学》
CAS
2019年第18期3182-3185,共4页
Journal of Modern Oncology
基金
陕西省自然科学基础研究项目(编号:2019JM-524)
陕西省卫生健康科研基金项目(编号:2018A004)